Release of inflammatory mediators (PGE2, IL-6) by fenofibric acid-photosensitized human keratinocytes and fibroblasts.
Ultraviolet-A radiation has weak effects on the release of inflammatory mediators by skin cells due to the poor overlap between UVA wavelengths and the absorption spectra of the relevant chromophores of key biomolecules. However, this situation could be very different in the presence of a photosensitizing drug. To investigate this issue, we have irradiated human skin cells (keratinocytes and fibroblasts) in the presence of fenofibric acid (the active phototoxic metabolite of fenofibrate). The results of this research show a dual effect on the production/release of inflammatory mediators: the synthesis of the proinflammatory cytokine interleukin-6 becomes strongly inhibited at photosensitizer concentrations that clearly stimulate the production of prostaglandins (PGE2) by skin cells. We have found evidences showing that the de novo synthesis of cytokines is inhibited in photosensitized cells due to the fact that cellular mRNA is degraded. Interestingly, when the medium taken from irradiated cultures is added to nonexposed cells, a significant stimulation of cytokine synthesis is observed that can be inhibited by anti-PGE2 antibodies. These observations may be relevant in vivo, where prostaglandins released by photosensitized skin cells could stimulate cytokine synthesis by underlying, nonirradiated cells.
Terencio
M C
MC
Departamento de Farmacología, Facultad de Farmacia, Universidad de Valencia, Burjasot, Spain.
Guillén
I
I
Gómez-Lechón
M J
MJ
Miranda
M A
MA
Castell
J V
JV
D002478:Cells, Cultured; D015232:Dinoprostone / Q000096:biosynthesis*; D011345:Fenofibrate / Q000031:analogs & derivatives* / Q000494:pharmacology; D005347:Fibroblasts / Q000187:drug effects / Q000502:physiology / Q000528:radiation effects; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D007375:Interleukin-1 / Q000494:pharmacology; D015850:Interleukin-6 / Q000096:biosynthesis*; D015603:Keratinocytes / Q000187:drug effects* / Q000502:physiology / Q000528:radiation effects; D008297:Male; D017319:Photosensitizing Agents / Q000494:pharmacology*; D012867:Skin / Q000166:cytology; D014466:Ultraviolet Rays
D000960:Hypolipidemic Agents; D007375:Interleukin-1; D015850:Interleukin-6; D017319:Photosensitizing Agents; C006012:fenofibric acid; D015232:Dinoprostone; D011345:Fenofibrate